MX351740B - Sintesis de derivados de 2-carboxamida-cicloamino-urea. - Google Patents

Sintesis de derivados de 2-carboxamida-cicloamino-urea.

Info

Publication number
MX351740B
MX351740B MX2017005292A MX2017005292A MX351740B MX 351740 B MX351740 B MX 351740B MX 2017005292 A MX2017005292 A MX 2017005292A MX 2017005292 A MX2017005292 A MX 2017005292A MX 351740 B MX351740 B MX 351740B
Authority
MX
Mexico
Prior art keywords
synthesis
urea derivatives
carboxamide cycloamino
cycloamino urea
carboxamide
Prior art date
Application number
MX2017005292A
Other languages
English (en)
Inventor
Erb Bernhard
Sylvie Gallou Isabelle
Karl Kleinbeck Florian
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX351740(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX351740B publication Critical patent/MX351740B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Abstract

En la presente se proporcionan procesos y compuestos intermediarios útiles para la preparación de los derivados de 2-carboxamida-cicloamino-urea de la fórmula (X): (ver Fórmula) y de los intermediarios útiles para los mismos.
MX2017005292A 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea. MX351740B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (1)

Publication Number Publication Date
MX351740B true MX351740B (es) 2017-10-26

Family

ID=45787206

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013010132A MX347348B (es) 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea.
MX2017005292A MX351740B (es) 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2013010132A MX347348B (es) 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea.

Country Status (32)

Country Link
US (3) US9650373B2 (es)
EP (1) EP2681192B1 (es)
JP (1) JP6022485B2 (es)
KR (1) KR101851421B1 (es)
CN (2) CN106083840B (es)
AR (2) AR088714A1 (es)
AU (1) AU2012222346B2 (es)
BR (1) BR112013021882A2 (es)
CA (1) CA2828509C (es)
CL (1) CL2013002521A1 (es)
CO (1) CO6751286A2 (es)
DK (1) DK2681192T3 (es)
EA (4) EA032802B1 (es)
EC (1) ECSP13012914A (es)
ES (1) ES2663717T3 (es)
GT (1) GT201300211A (es)
HU (1) HUE036319T2 (es)
IL (1) IL228023A (es)
MA (1) MA34982B1 (es)
MX (2) MX347348B (es)
MY (1) MY163214A (es)
NO (1) NO2681192T3 (es)
PE (1) PE20140917A1 (es)
PL (1) PL2681192T3 (es)
PT (1) PT2681192T (es)
SG (1) SG192793A1 (es)
SI (1) SI2681192T1 (es)
TN (1) TN2013000354A1 (es)
TW (2) TWI597279B (es)
UA (1) UA112539C2 (es)
WO (1) WO2012117071A1 (es)
ZA (1) ZA201306174B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
JP7014737B2 (ja) 2017-01-20 2022-02-01 株式会社ペーターズ スケートボード用ハンドル及びハンドル付きスケートボード
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
BR0013899A (pt) 1999-09-10 2003-07-08 Merck & Co Inc Composto, composição farmacêutica, processos de tratamento ou prevenção de câncer, de uma doença em que a angiogênese esteja implicada, da vascularização retinal, da retinopatia diabética, da degeneração macular relacionada a idade, de doenças inflamatórias, de uma doença ou condições dependentes da tirosina quinase, de patologias associadas com ossos, e, processos para produzir uma composição farmacêutica, e de reduzir ou prevenir dano tecidual em seguida a um evento isquêmico cerebral
TW200519106A (en) * 2003-05-02 2005-06-16 Novartis Ag Organic compounds
US8455658B2 (en) * 2006-01-25 2013-06-04 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
CN101952282A (zh) * 2007-12-20 2011-01-19 诺瓦提斯公司 用作pi 3激酶抑制剂的噻唑衍生物
EP2235983B1 (en) * 2007-12-21 2011-07-20 Telefonaktiebolaget LM Ericsson (publ) Method, apparatus and computer program for handover from a first access point to a second access point
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
MY163214A (en) 2017-08-30
BR112013021882A2 (pt) 2016-07-19
IL228023A0 (en) 2013-09-30
ECSP13012914A (es) 2013-11-29
EA201792068A2 (ru) 2018-01-31
GT201300211A (es) 2014-12-30
ZA201306174B (en) 2014-05-28
DK2681192T3 (en) 2018-04-16
US20170355677A1 (en) 2017-12-14
CN103402982A (zh) 2013-11-20
JP6022485B2 (ja) 2016-11-09
AR088714A1 (es) 2014-07-02
WO2012117071A1 (en) 2012-09-07
UA112539C2 (uk) 2016-09-26
TWI607994B (zh) 2017-12-11
CA2828509C (en) 2018-11-20
EA201691331A1 (ru) 2017-01-30
EP2681192A1 (en) 2014-01-08
CN106083840A (zh) 2016-11-09
TWI597279B (zh) 2017-09-01
KR101851421B1 (ko) 2018-04-23
CN106083840B (zh) 2020-01-03
SI2681192T1 (en) 2018-04-30
AU2012222346A1 (en) 2013-08-29
PL2681192T3 (pl) 2018-06-29
KR20140009432A (ko) 2014-01-22
EA201792068A3 (ru) 2018-05-31
NZ614173A (en) 2015-04-24
TW201722916A (zh) 2017-07-01
US20170240509A1 (en) 2017-08-24
PT2681192T (pt) 2018-04-02
US9776966B2 (en) 2017-10-03
ES2663717T3 (es) 2018-04-16
HUE036319T2 (hu) 2018-06-28
US9650373B2 (en) 2017-05-16
MX2013010132A (es) 2013-10-30
PE20140917A1 (es) 2014-08-14
CO6751286A2 (es) 2013-09-16
JP2014511387A (ja) 2014-05-15
EA201892052A1 (ru) 2019-02-28
MA34982B1 (fr) 2014-03-01
AR123584A2 (es) 2022-12-21
TW201247660A (en) 2012-12-01
AU2012222346B2 (en) 2015-05-07
SG192793A1 (en) 2013-09-30
TN2013000354A1 (en) 2015-01-20
EA032802B1 (ru) 2019-07-31
CN103402982B (zh) 2016-07-13
MX347348B (es) 2017-04-17
CA2828509A1 (en) 2012-09-07
EA025381B1 (ru) 2016-12-30
IL228023A (en) 2017-04-30
EP2681192B1 (en) 2017-12-27
US10059670B2 (en) 2018-08-28
NO2681192T3 (es) 2018-05-26
CL2013002521A1 (es) 2014-02-14
US20130331579A1 (en) 2013-12-12
EA201391267A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
PH12015500263A1 (en) New bicyclic derivatives
ZA201209297B (en) 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
TN2011000673A1 (en) Bace inhibitors
TN2013000354A1 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
MX2014002770A (es) Nuevos derivados dihidroquinolina-2-ona.
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
AU2011232516A8 (en) Chemical compounds
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
NI200900151A (es) Nuevo procedimiento de síntesis de la agomelatina.
MY169267A (en) New aryl-quinoline derivatives
NI200900153A (es) Nuevo procedimiento de síntesis de la agomelatina.
MX2012008141A (es) Compuestos y metodos.
MX2015017156A (es) Inhibidores de bace.
CL2012000278A1 (es) Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
MX357509B (es) Sintesis de cleistantina a y derivados de la misma.
GB201107985D0 (en) Process
NI200900152A (es) Nuevo procedimiento de síntesis de la agomelatina
ZA201301799B (en) Process for the preparation of pan-cdk inhibitors of the formula (i),and intermediates of the preparation
MX337610B (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
CU20130092A7 (es) Nuevo procedimiento para la síntesis de la agomelatina
GB2511240A (en) Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
MX2013002656A (es) Nuevo proceso.
IN2012DN00346A (es)